Theratechnologies Inc. (TH.TO)
| Previous Close | 3.0100 |
| Open | 3.0800 |
| Bid | 3.0500 x 0 |
| Ask | 3.0900 x 0 |
| Day's Range | 3.0800 - 3.1300 |
| 52 Week Range | 2.6600 - 5.6100 |
| Volume | |
| Avg. Volume | 16,466 |
| Market Cap | 293.926M |
| Beta (5Y Monthly) | 1.60 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4760 |
| Earnings Date | Jul 13, 2022 - Jul 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.55 |
- Baystreet
Stocks in play: Theratechnologies Inc.
Announced that Elif McDonald has joined the team as Senior Director, Investor Relations. McDonald brings ...
- GlobeNewswire
Theratechnologies Announces New Head of Investor Relations
MONTREAL, May 31, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Elif McDonald has joined the team as Senior Director, Investor Relations. "We are pleased to welcome Elif to lead our dedicated in-house investor relations efforts,” said Paul Lévesque, President and Chief Executive Officer, Theratechnologies. “H
- GlobeNewswire
Appointments in Conjunction With Theratechnologies Annual Meeting
MONTREAL, May 10, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG, LLP, as the Company’s auditors for the current fiscal year. Shareho
